Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a botanical formula tame inflammation and protect aging hearts?

NCT ID NCT06065241

Knowledge-focused Sponsor: LL Prosper Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a plant-based supplement called LLP-01 in 32 healthy adults aged 50 to 75. Researchers measured changes in blood markers related to inflammation and heart health, as well as grip strength and well-being. The goal was to see if the supplement could improve these measures compared to a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

32 people

The number who actually took part.

Started

Sep 2023

Finished

Mar 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 50-75 years of age * Any sex / gender * All ethnicities * Able to participate in a 2 month trial * Able to provide informed consent * Participant must be able to comply with treatment plan and laboratory tests * Can swallow 00 size capsules Exclusion Criteria: * Any clinically diagnosed medical disease or disorder that requires prescribed medication(s) * Currently on any anticoagulant medicines, such as warfarin * Planned surgical procedure during study period * Consumption of any supplements within the last 30 days that include the following botanicals/ingredients: green tea extract, Ashwagandha, Fisetin, Curcumin/Turmeric extract, Rosemary extract, Cordyceps, Ginseng * Allergy or other sensitivity to any of the botanicals in the investigated product * Currently or have been sick (bacterial or viral infection) in the last 14 days * Alcoholism or drug addiction * Participation in a clinical research trial within 30 days prior to enrollment in this trial * Cognitive impairment, illiteracy, inability or unwillingness to give voluntary informed consent * Unable or unwilling to provide required blood sample for testing and for use in a scientific publication (personal information undisclosed) * Participants with any condition that may preclude venipuncture/ venous blood draw

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Inflammation inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aging Inflammation

Contacts and locations

Locations

  • LL Prosper Inc.

    San Diego, California, 92121, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.